A funding round has pulled in $10 million for Zyga Technology, maker of the FDA-cleared SImmetry Sacroiliac Joint Fusion System designed to treat hip and lower back pain. The company also hopes to obtain CE mark approval in Europe for its Glyder Facet Resurfacing System, which is used to treat chronic facetogenic pain, by the close of the year.

Related Summaries